Berlin, Germany

Frauke Dreyer

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: B.r.a.h.m.s Gmbh. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frauke Dreyer - Innovator in Medical Diagnostics

Introduction: Frauke Dreyer is a prominent inventor based in Berlin, Germany. She is associated with B.R.A.H.M.S GmbH, where she contributes to advancements in medical diagnostics. Although she currently holds no granted patents, her work is focused on innovative methods for diagnosing and predicting trauma-related complications.

Latest Patent Applications: Frauke Dreyer's latest patent applications include significant inventions aimed at improving patient outcomes. One application is titled "Pro-ADM for Prognosis of Trauma-Related Complications in Polytrauma Patients." This invention relates to a method for diagnosing and assessing the risk of subsequent trauma-related complications in polytrauma patients. It involves analyzing a sample from the patient to determine the level of pro-adrenomedullin (proADM), which correlates with the likelihood of complications.

Another application is "Histones and/or ProADM as Markers Indicating Organ Dysfunction." This invention focuses on diagnosing and monitoring organ dysfunction in subjects. It includes methods for determining levels of specific histones and proADM in samples, which serve as indicators of organ health. Additionally, the invention encompasses kits designed for implementing these diagnostic methods.

Conclusion: Frauke Dreyer is making significant strides in the field of medical diagnostics through her innovative patent applications. Her work has the potential to enhance the understanding and treatment of trauma-related complications and organ dysfunction.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…